Zenobia Therapeutics

Zenobia Therapeutics Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 2
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $398K
Latest Deal Amount
  • Investors
  • 2

Zenobia Therapeutics General Information


Developer of medical treatments designed to treat neurodegenerative diseases. The company's medical treatments uses fragment-based therapies and provides tools that helps researchers to complete target validation and lead discovery programs, enabling them to discover treatments for neurology related diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 3550 General Atomics Court
  • Building B, Suite 435
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Zenobia Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jan-2016 $398K Completed Generating Revenue
2. Grant 01-Jan-2010 00000 Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue

Zenobia Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Vicki Nienanber Co-Founder, CSO & President
Robert Meadows Ph.D Co-Founder

Zenobia Therapeutics Investors (2)

To view Zenobia Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

Ready to get started?

Request a free trial